(Q40938157)

25 September 2017

1 reference

title

Novel treatment options in the severe beta-globin disorders (English)

1 reference

25 September 2017

Rodgers GP

1

1 reference

25 September 2017

Rachmilewitz EA

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

British Journal of Haematology

25 September 2017

published in

1 reference

25 September 2017

volume

91

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

263-268

1 reference

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Fetal hemoglobin reactivation in baboon and man: a short perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Sickle cell anemia--basic research reaches the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Management of sickle cell disease; lessons from the Jamaican Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

Haemoglobinopathies and red cell membrane function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05288.X

10.1111/J.1365-2141.1995.TB05288.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference